Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Lowe

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Regulatory Peptides|August 27, 1996
Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approachJ A Lowe, W Qian, S McLean, et al.
Regulatory Peptides|July 2, 1993
Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptorU Gether, T E Johansen, R M Snider, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptorsU Gether, Y Yokota, X Emonds-Alt, et al.
Environmental Science. Processes & Impacts|June 19, 2015
Modelling the increased frequency of extreme sea levels in the Ganges-Brahmaputra-Meghna delta due to sea level rise and other effects of climate changeS Kay, J Caesar, J Wolf, et al.
Journal of Medicinal Chemistry|October 28, 1994
5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonistsJ A Lowe, D L Hageman, S E Drozda, et al.
Journal of Medicinal Chemistry|September 2, 1994
Aza-tricyclic substance P antagonistsJ A Lowe, S E Drozda, S McLean, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonistT J Rosen, K J Coffman, S McLean, et al.
Science (New York, N.Y.)|January 25, 1991
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonistS McLean, A H Ganong, T F Seeger, et al.
Nuclear Medicine and Biology|May 1, 1993
Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studiesR B Del Rosario, T J Mangner, D L Gildersleeve, et al.
Journal of Medicinal Chemistry|July 10, 1992
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisstJ A Lowe, S E Drozda, R M Snider, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Regulatory Peptides|August 27, 1996
Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approachJ A Lowe, W Qian, S McLean, et al.
Regulatory Peptides|July 2, 1993
Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptorU Gether, T E Johansen, R M Snider, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993
Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptorsU Gether, Y Yokota, X Emonds-Alt, et al.
Environmental Science. Processes & Impacts|June 19, 2015
Modelling the increased frequency of extreme sea levels in the Ganges-Brahmaputra-Meghna delta due to sea level rise and other effects of climate changeS Kay, J Caesar, J Wolf, et al.
Journal of Medicinal Chemistry|October 28, 1994
5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonistsJ A Lowe, D L Hageman, S E Drozda, et al.
Journal of Medicinal Chemistry|September 2, 1994
Aza-tricyclic substance P antagonistsJ A Lowe, S E Drozda, S McLean, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonistT J Rosen, K J Coffman, S McLean, et al.
Science (New York, N.Y.)|January 25, 1991
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonistS McLean, A H Ganong, T F Seeger, et al.
Nuclear Medicine and Biology|May 1, 1993
Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studiesR B Del Rosario, T J Mangner, D L Gildersleeve, et al.
Journal of Medicinal Chemistry|July 10, 1992
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisstJ A Lowe, S E Drozda, R M Snider, et al.
Pageof 9